Paper published in a journal (Scientific congresses and symposiums)
Predictive biomarkers of everolimus efficacy in HER2+ advanced breast cancer : combined exploratory analysis from BOLERO-1 and BOLERO-3
Slamon, Dennis; Hurvitz, Sara; Chen, David et al.
2015In Journal of Clinical Oncology, 33 (suppl ; abstr 512)
Peer Reviewed verified by ORBi
 

Files


Full Text
Predictive biomarkers of everolimus efficacy in HER2+ advanced breast cancer ... - abstract.pdf
Publisher postprint (809.89 kB)
Request a copy
Annexes
Predictive biomarkers of everolimus efficacy in HER2+ advanced breast cancer ... - dias.pdf
Publisher postprint (3.79 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
oncology
Disciplines :
Oncology
Author, co-author :
Slamon, Dennis
Hurvitz, Sara
Chen, David
Andre, Fabrice
Tseng, Ling-Ming
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Wilks, Sharon
O'Regan, Ruth
Isaacs, Claudine
Toi, Masakazu
Burris, Howard
He, Wei
Riester, Markus
Robinson, Douglas
Taran, Tetiana
Gianni, Luca
More authors (6 more) Less
Language :
English
Title :
Predictive biomarkers of everolimus efficacy in HER2+ advanced breast cancer : combined exploratory analysis from BOLERO-1 and BOLERO-3
Publication date :
2015
Event name :
2015 ASCO Annual Meeting
Event place :
Chicago, United States
Event date :
May 29 - June 2 2015
Audience :
International
Journal title :
Journal of Clinical Oncology
ISSN :
0732-183X
eISSN :
1527-7755
Publisher :
American Society of Clinical Oncology, Alexandria, United States - Virginia
Volume :
33
Issue :
suppl ; abstr 512
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 02 February 2016

Statistics


Number of views
67 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi